跳至主要内容
临床试验/NCT03102177
NCT03102177已完成早期 1 期

Hypothyroidism Treatment in Aging and Thyroid Cancer

Georgetown University0 个研究点目标入组 41 人开始时间: 2011年5月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
41
主要终点
CL/F

研究概览

简要总结

This study was a prospective, single-center, open-label, non-randomized, pharmacokinetic study using stable isotope carbon-13 labeled levothyroxine

详细描述

Setting The study was conducted on the clinical research unit of an academic medical center.

Participants Adults of any age being treated with levothyroxine for hypothyroidism were studied.

Interventions A single dose of 13C- LT4 was administered to hypothyroid subjects taking levothyroxine replacement.

Main Outcomes and Measures Eighteen serial plasma samples were collected. One sample was obtained before the 13C- LT4 dose and the remainder over the 312-hour period post-dosing. 13C- LT4 concentration was quantified using validated liquid chromatography tandem mass spectrometry methods. Pharmacokinetic analysis was conducted using linear log trapezoidal non-compartmental analysis using Phoenix 6.4.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >21 years at the time of consent
  • euthyroidism while undergoing treatment with LT4
  • no other serious illness
  • ability to give written informed consent.

排除标准

  • baseline hematocrit lower than 28.0%
  • TSH greater than 4.5 mIU/L
  • kidney dysfunction
  • concomitant use of drugs that affect thyroidal axis interactions

研究组 & 干预措施

Stable isotope arm

Experimental

Measurement of blood levels of labelled levothyroxine after administration of single oral dose of stable isotope levothyroxine

干预措施: Administration of stable Isotope labeled levothyroxine (Drug)

结局指标

主要结局

CL/F

时间窗: 120 hours

oral clearance rate (defined as the ratio of dose administered to AUC0-∞)

V/F

时间窗: 120 hours

apparent volume of distribution (estimated by CL/F/ λ)

t-half

时间窗: 120 hours

the half-life of the terminal disposition phase (t-half) estimated by ln(2)/λ .

次要结局

  • V/F analysed by age groups(120 hours)
  • t-half by age groups(120 hours)
  • CL/F analysed by age groups(120 hours)

研究者

申办方类型
Other
责任方
Sponsor

相似试验